Literature DB >> 17989153

Reported and unreported exacerbations of COPD: analysis by diary cards.

Kesavaperumal Vijayasaratha1, Robert A Stockley.   

Abstract

BACKGROUND: Exacerbations of COPD are a major cause of morbidity and mortality; however, it has been reported that nearly half of such episodes based on symptoms are classified as "unreported" (no change in treatment), although the reasons are unknown.
METHOD: We used a symptom-based diary card to study 155 symptom-defined episodes (74 episodes in which treatment was not changed) in 19 patients with alpha(1)-antitrypsin deficiency.
RESULTS: The average length for the untreated episodes (time to resolution of all symptoms) was shorter than treated episodes (mean +/- SE, 8.3 +/- 1.0 days vs 16.1 +/- 1.6 days; p < 0.001). Of most importance, the patients documented feeling less well than usual for an average of only 1.9 +/- 0.4 days for untreated episodes, vs 11.7 +/- 1.7 days for treated episodes (p < 0.001). We developed a scoring system based on the symptoms of breathlessness, well-being, sputum color, and volume to quantify the episodes. The scores were higher for the first day of the treated episodes than untreated episodes (33.5 +/- 0.6 vs 28.4 +/- 0.5, respectively; p < 0.001), and the treated episodes had total scores that exceeded the baseline more than the untreated episodes (160.5 +/- 20.0 vs 43.4 +/- 6.6; p < 0.001). Antibiotics or steroids were started 4.4 +/- 0.5 days and 4.9 +/- 1.8 days on average, respectively, after symptoms changed, suggesting that the early return of well-being to normal is central to the episodes described as unreported (untreated) by others.
CONCLUSION: The diary card analysis described here provides a tool to document therapies that influence health-care-dependent exacerbations of COPD.

Entities:  

Mesh:

Year:  2007        PMID: 17989153     DOI: 10.1378/chest.07-1692

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  22 in total

1.  The St. George's Respiratory Questionnaire Definition of Chronic Bronchitis May Be a Better Predictor of COPD Exacerbations Compared With the Classic Definition.

Authors:  Victor Kim; Huaqing Zhao; Elizabeth Regan; MeiLan K Han; Barry J Make; James D Crapo; Paul W Jones; Jeffrey L Curtis; Edwin K Silverman; Gerard J Criner
Journal:  Chest       Date:  2019-05-15       Impact factor: 9.410

2.  Exacerbations of Lung Disease in Alpha-1 Antitrypsin Deficiency.

Authors:  Daniel J Smith; Paul R Ellis; Alice M Turner
Journal:  Chronic Obstr Pulm Dis       Date:  2021-01

3.  The Christmas season as a risk factor for chronic obstructive pulmonary disease exacerbations.

Authors:  Neil W Johnston; Andrew McIvor; Kim Lambert; Justina M Greene; Pat Hussack; Maria Gerhardsson de Verdier; Tim Higenbottam; Jonathan Lewis; Paul Newbold; Athula Herath; Martin Jenkins
Journal:  Can Respir J       Date:  2010 Nov-Dec       Impact factor: 2.409

4.  Impact of Proactive Integrated Care on Chronic Obstructive Pulmonary Disease.

Authors:  Patricia B Koff; Sung-Joon Min; Tammie J Freitag; Debora L P Diaz; Shannon S James; Norbert F Voelkel; Derek J Linderman; Fernando Diaz Del Valle; Jonathan K Zakrajsek; Richard K Albert; Todd M Bull; Arne Beck; Thomas J Stelzner; Debra P Ritzwoller; Christine M Kveton; Stephanie Carwin; Moumita Ghosh; Robert L Keith; John M Westfall; R William Vandivier
Journal:  Chronic Obstr Pulm Dis       Date:  2021-01

5.  How do COPD patients respond to exacerbations?

Authors:  Jaap C A Trappenburg; David Schaap; Evelyn M Monninkhof; Jean Bourbeau; Gerdien H de Weert-van Oene; Theo J M Verheij; Jan-Willem J Lammers; Augustinus J P Schrijvers
Journal:  BMC Pulm Med       Date:  2011-08-19       Impact factor: 3.317

Review 6.  Extrafine beclometasone diproprionate/formoterol fumarate: a review of its effects in chronic obstructive pulmonary disease.

Authors:  Dave Singh; Massimo Corradi; Monica Spinola; Stefano Petruzzelli; Alberto Papi
Journal:  NPJ Prim Care Respir Med       Date:  2016-06-16       Impact factor: 2.871

7.  Patterns and characterization of COPD exacerbations using real-time data collection.

Authors:  Stanley I Ejiofor; Jan Stolk; Pablo Fernandez; Robert A Stockley
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-01-25

8.  Action Plan to enhance self-management and early detection of exacerbations in COPD patients; a multicenter RCT.

Authors:  Jaap C A Trappenburg; Lieselotte Koevoets; Gerdien H de Weert-van Oene; Evelyn M Monninkhof; Jean Bourbeau; Thierry Troosters; Theo J M Verheij; Jan-Willem J Lammers; Augustinus J P Schrijvers
Journal:  BMC Pulm Med       Date:  2009-12-29       Impact factor: 3.317

9.  Relationship between frequency, length, and treatment outcome of exacerbations to baseline lung function and lung density in alpha-1 antitrypsin-deficient COPD.

Authors:  Kesavaperumal Vijayasaratha; Robert A Stockley
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-11-27

Review 10.  Exacerbation rate, health status and mortality in COPD--a review of potential interventions.

Authors:  Terence A R Seemungal; John R Hurst; Jadwiga A Wedzicha
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.